Myomo, Inc. Announces Revenue Guidance for the Fourth Quarter and Fiscal Year Ended December 31, 2020
January 11, 2021 at 06:00 am
Share
Myomo, Inc. announced revenue guidance for the fourth quarter and fiscal year ended December 31, 2020. For the fourth quarter the company expects revenue for the fourth quarter of 2020 to be between $3.2 million and $3.7 million, representing an increase of 110% to 143%, compared with the fourth quarter of 2019.
For the full year, the company expects revenue to be between $7.0 million and $7.5 million, representing an increase of 84% to 97%, compared with the full year 2019.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patientâs own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individualâs ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteranâs administration, and others.
MYOMO, INC. 
